DECRYPTING THE T CELL ANTIGEN LANDSCAPE IN NEURODEGENERATION

Loading...
Thumbnail Image
Degree type
PhD
Graduate group
Bioengineering
Discipline
Immunology and Infectious Disease
Engineering
Engineering
Subject
CD8 T cells
Neurodegeneration
Neuroimmunology
Single cell multiomics
Systems Immunology
Funder
Grant number
License
Copyright date
01/01/2025
Distributor
Related resources
Author
Chizari, Shahab
Contributor
Abstract

The landscape of T cell and antigen interactions are critical to disease initiation and pathogenesis. Although once thought of as immune privileged, the central nervous system (CNS) shows enhanced CD8 T cell activation and clonal expansion across multiple neurodegenerative and inflammatory conditions. However, in most cases, the implicated antigen(s) remain unknown. In this dissertation, different mechanisms of antigen generation in neurodegeneration are explored by deeply profiling human cohorts of myelin oligodendrocyte glycoprotein-associated disease (MOGAD), amyotrophic lateral sclerosis (ALS), and inclusion body myositis (IBM) using high-throughput multiomic antigen screening and in vitro functional assays. MOGAD is a recently characterized antibody-mediated demyelinating disorder of the CNS. We present data demonstrating the occurrence of a high-frequency CD8+ T cell clone capable of recognizing a self-antigen derived from the NMDA-NR1 protein. The presence of activated CD8+ T cells targeting NMDA-NR1 suggests that cell-mediated cytotoxicity may contribute to disease pathogenesis. Aggregation and nuclear depletion of the RNA binding protein TDP-43 are the crucial pathological features ALS and IBM, two degenerative diseases of the CNS and muscle. The loss of TDP-43 nuclear function results in the aberrant inclusion of cryptic exons in mRNA transcripts, leading to the expression of de novo proteins. Here, we identify “cryptic epitopes”, neoantigens induced by TDP-43 dysfunction, deriving from HDGFL2 and IGLON5 which are recognized by clonally expanded populations of CD8+ T cells in ALS and IBM patients. We demonstrate that T cells engineered to express the identified TCRs can bind and activate in response to the cryptic epitopes and are able to kill TDP-43 deficient astrocytes. Finally, we detect the HDGFL2 cryptic peptide and multiple other TDP-43 cryptic exons in IBM skeletal muscle, where their presence correlates with enrichment of T cell and class I antigen presentation pathways. This work identifies for the first time specific T cell antigens in ALS and IBM, directly linking adaptive immune response to TDP-43 pathology.

Advisor
Jiang, Ning Jenny
Good, Matthew, C
Date of degree
2025
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation